SCHEMBL7576607

SCHEMBL7576607

CCOC(=O)C1=C[N+]([O-])(C2CC2)c2c(ccc(Br)c2OC)C1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.38
MAPT P10636 2/20 0.38
KMT2A Q03164 2/20 0.38
USP2 O75604 1/20 0.38
ALOX15 P16050 1/20 0.38
ALDH1A1 P00352 4/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPSR1 Q6W5P4 1/20 0.33
CA1 P00915 3/20 0.32
CA2 P00918 3/20 0.32
CA9 Q16790 3/20 0.32
CA12 O43570 2/20 0.32
PPARG P37231 1/20 0.32
CA7 P43166 1/20 0.32
SMAD3 P84022 2/20 0.32
APAF1 O14727 1/20 0.32
ESR1 P03372 1/20 0.32
MAPK1 P28482 1/20 0.31
KDM4E B2RXH2 2/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7585608 0.89 APAF1 (0.32) MEN1MAPTKMT2AUSP2ALOX15
SCHEMBL7574850 0.79 SMAD3 (0.39) MEN1KMT2AALDH1A1SMN1; SMN2SMAD3
SCHEMBL5059324 0.62 SMAD3 (0.35) MEN1MAPTKMT2AALDH1A1SMN1; SMN2
SCHEMBL1648180 0.62 MAPT (0.59) MEN1MAPTKMT2AUSP2ALOX15
SCHEMBL18468249 0.62 MEN1 (0.52) MEN1MAPTKMT2AUSP2ALOX15
SCHEMBL8492599 0.62 MAPT (0.52) MEN1MAPTKMT2AUSP2ALOX15
SCHEMBL7584565 0.62 ALDH1A1 (0.41) MEN1MAPTKMT2AALDH1A1SMN1; SMN2
SCHEMBL16108072 0.60 MEN1 (0.50) MEN1MAPTKMT2AUSP2ALOX15
SCHEMBL8495682 0.60 KMT2A (0.47) MEN1MAPTKMT2AUSP2ALOX15
SCHEMBL20478946 0.60 KMT2A (0.47) MEN1MAPTKMT2AUSP2ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020049223-A1 Quinoline and naphthyridine carboxylic acid antibacterials ABBOTT LABORATORIES 2002-04-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020049223-A1 Quinoline and naphthyridine carboxylic acid antibacterials NQO2, NQO1, NDUFA7 MEN1 1235/4885MAPT 3354/4885KMT2A 3343/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.